These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 458830)

  • 21. Immunological determination of porphobilinogen deaminase as a diagnostic measure in acute intermittent porphyria.
    Lannfelt L
    J Clin Chem Clin Biochem; 1990 May; 28(5):273-8. PubMed ID: 2380662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A microassay for uroporphyrinogen I synthase, one of three abnormal enzyme activities in acute intermittent porphyria, and its application to the study of the genetics of this disease.
    Sassa S; Granick S; Bickers DR; Bradlow HL; Kappas A
    Proc Natl Acad Sci U S A; 1974 Mar; 71(3):732-6. PubMed ID: 4522787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies in porphyria. V. Drug oxidation rates in hereditary hepatic porphyria.
    Anderson KE; Alvares AP; Sassa S; Kappas A
    Clin Pharmacol Ther; 1976 Jan; 19(1):47-54. PubMed ID: 1245093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recurrence risk estimation of acute intermittent porphyria based on analysis of porphobilinogen deaminase activity: a Bayesian approach.
    Bonaïti-Pellié C; Phung L; Nordmann Y
    Am J Med Genet; 1984 Dec; 19(4):755-62. PubMed ID: 6517099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic regulation of the red cell uroporphyrinogen-I-synthetase level in families with acute intermittent porphyria.
    Wetterberg L; Floderus Y; Thunell S; Iselius L; Lindsten J
    Clin Genet; 1983 Dec; 24(6):403-6. PubMed ID: 6652953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uroporphyrinogen-I-synthetase activity in red blood cells of lead-exposed workers.
    El-Waseef A
    Acta Med Acad Sci Hung; 1982; 39(1-2):95-100. PubMed ID: 7180366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute intermittent porphyria in two patients on anticonvulsant therapy and with normal erythrocyte porphobilinogen deaminase activity.
    Herrick AL; McColl KE; Moore MR; Brodie MJ; Adamson AR; Goldberg A
    Br J Clin Pharmacol; 1989 Apr; 27(4):491-7. PubMed ID: 2497768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased activity of porphobilinogen deaminase in erythrocytes during attacks of acute intermittent porphyria.
    Kostrzewska E; Gregor A
    Ann Clin Res; 1986; 18(4):195-8. PubMed ID: 3789651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variant of acute intermittent porphyria with normal erythrocyte uroporphyrinogen-I-synthase activity.
    Mustajoki P; Tenhunen R
    Eur J Clin Invest; 1985 Oct; 15(5):281-4. PubMed ID: 3935460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evaluation of the diagnostic usefulness of determining porphobilinogen deaminase activity in the erythrocytes in patients with acute intermittent porphyria and in carriers of the gene of this type of porphyria].
    Gregor A; Kocyłowski M; Kostrzewska E
    Przegl Lek; 1986; 43(11):703-5. PubMed ID: 3575772
    [No Abstract]   [Full Text] [Related]  

  • 31. Erythrocyte uroporphyrinogen I synthase activity in diagnosis of acute intermittent porphyria.
    Peterson LR; Hamernyik P; Bird TD; Labbé RF
    Clin Chem; 1976 Nov; 22(11):1835-40. PubMed ID: 975542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Genetic studies of families of patients with porphyria. Determination of uroporphyrinogen I synthase in the erythrocytes].
    Gregor A; Kostrzewska E; Kocyłowski M; Rudowski W
    Pol Arch Med Wewn; 1979 Jul; 62(1):15-21. PubMed ID: 503882
    [No Abstract]   [Full Text] [Related]  

  • 33. Why is the patient with acute intermittent porphyria not light sensitive?
    Wetterberg L; Thunell S; Zetterlund P
    Acta Derm Venereol Suppl (Stockh); 1982; 100():73-4. PubMed ID: 6962637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uroporphyrinogen synthetase in erythrocytes. Its diagnostic value in latent acute intermittent porphyria with special regard to the gene penetrance.
    With TK; Pedersen JS
    Dan Med Bull; 1981 Mar; 28(1):27-34. PubMed ID: 7238130
    [No Abstract]   [Full Text] [Related]  

  • 35. New form of dual porphyria: coexistent acute intermittent porphyria and porphyria cutanea tarda.
    Doss MO
    Eur J Clin Invest; 1989 Feb; 19(1):20-5. PubMed ID: 2499457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diagnosis of acute intermittent porphyria on the basis of uroporphyrinogen I synthase activity in the erythrocytes; comparison of 2 methods].
    Kostrzewska E; Gregor A; Traczyk A; Rudowski W
    Pol Tyg Lek; 1979 Aug; 34(33):1305-7. PubMed ID: 514844
    [No Abstract]   [Full Text] [Related]  

  • 37. Protoporphyrinaemia and decreased activities of 5-aminolevulinic acid dehydrase and uroporphyrinogen I synthetase in erythrocytes of a Vitamin B6-deficient epileptic boy given valproic acid and carbamazepine.
    Haust HL; Poon HC; Carson R; VanDeWetering C; Peter F
    Clin Biochem; 1989 Jun; 22(3):201-11. PubMed ID: 2500271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variations in erythrocyte uroporphyrinogen I synthetase activity in non porphyrias.
    Blum M; Koehl C; Abecassis J
    Clin Chim Acta; 1978 Jul; 87(1):119-25. PubMed ID: 668133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreased red cell uroporphyrinogen I synthetase activity in intermittent acute porphyria.
    Strand LJ; Meyer UA; Felsher BF; Redeker AG; Marver HS
    J Clin Invest; 1972 Oct; 51(10):2530-6. PubMed ID: 5056653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA polymorphisms within the porphobilinogen deaminase gene in two Swedish families with acute intermittent porphyria.
    Lee JS; Anvret M; Lindsten J; Lannfelt L; Gellerfors P; Wetterberg L; Floderus Y; Thunell S
    Hum Genet; 1988 Aug; 79(4):379-81. PubMed ID: 2900803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.